Tomoyoshi Hatayama
3PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 16, 2025
CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug-Combination Trials.Tomoyoshi Hatayama, Seiichi Yasui
|Jul 14, 2022
CUSUMIN: A cumulative sum interval design for cancer phase I dose finding studies.Tomoyoshi Hatayama, Seiichi Yasui
|Mar 16, 2022
Safety and efficacy of apalutamide in Japanese patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo-controlled, phase III TITAN study.Hirotsugu Uemura, Gaku Arai, Hiroji Uemura
Pageof 1
